Low dosage Hydrate Inhibitors Market
Market Insights on Low dosage Hydrate Inhibitors covering sales outlook, demand forecast & up-to-date key trends
Low Dosage Hydrate Inhibitors Market By Product Type (Anti-Agglomerate (AA) Inhibitors, Kinetic Hydrate Inhibitors (KHIs)), Terrain Type (Onshore, Offshore) & Region - Forecast 2022 - 2029
Low Dosage Hydrate Inhibitors Market Outlook – 2022-2029
[243 pages Report] Sales in the global low dosage hydrate inhibitors market are slated to top US$ 75.3 Mn in 2022. Expanding at a healthy 8.1% CAGR, the market size is projected to total US$ 120.3 Mn by 2029.
|
Attribute |
Details |
|
Low Dosage Hydrate Inhibitors Market Estimated Size in 2022 |
US$ 75.3 Mn |
|
Low Dosage Hydrate Inhibitors Market Value-based CAGR (2022-2029) |
~8.1% |
|
Low Dosage Hydrate Inhibitors Market Projected Size in 2029 |
US$ 120.3 Mn |
The ability of low dosage hydrate inhibitors to reduce transportation and handling costs through decreased delivery frequency and chemical consumption is anticipated to propel the sales in the market.
These inhibitors can lower the maintenance of delivery systems and pumps, reduce the safety and environmental risks owing to lesser toxicity, and eliminate the need for methyl alcohol in downstream and topside operations.
Further, increasing exploration and production of crude oil is estimated to boost the growth in the market as low dosage hydrate inhibitors are extensively used in extraction processes to lower the formation of hydrate in the systems. It further aids in reducing the costs of refining and drilling systems used in the crude oil extraction sector.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Market Statistics |
Details |
|
H1,2021 (A) |
7.8% |
|
H1,2022 Projected (P) |
8.1% |
|
H1,2022 Outlook (O) |
7.6% |
|
BPS Change : H1,2022 (O) - H1,2022 (P) |
(-) 50 ↓ |
|
BPS Change : H1,2022 (O) - H1,2021 (A) |
(-) 20 ↓ |
A half-yearly comparison of the growth forecast for the market of low dosage hydrate inhibitors has been presented by Future Market Insights. Low dosage hydrate inhibitors are used to prevent the formation of hydrate compounds.
Due to this property, they are used in a variety of applications such as pipeline systems and others. Some of the key trends which are observed include research & development by the key players along with the acquisitions & partnership activities, which are likely to impact the growth of the market.
The variation between the BPS values observed in the low dosage hydrate inhibitor market in H1, 2022 - Outlook over first half of 2022 Projected reflects a decline of 50 bps, according to FMI analysis. In comparison to H1-2021, the market is expected to again fall by 20 basis points in first half of 2022.
The market's slow growth outlook in the first half of the forecast period can be attributed to the availability of substitutes in the market, such as High Throughput Experimentation (HTE) and thermodynamic inhibitors, as well as a lack of end users awareness about the benefits of low-dose hydrate inhibitors along with increase in the pricing of raw materials.
Despite certain obstacles, the industry has some promising prospects, including an increasing number of offshore oil & gas operations, drilling exploration wells, and finding green hydrate inhibitors are anticipated to bolster the demand for these inhibitors.
2014-2021 Low Dosage Hydrate Inhibitors Market Outlook in Comparison to 2022-2029 Growth Forecast
The low dosage hydrate inhibitors market is expected to grow at a robust 8.1% CAGR between 2022 and 2029, up from 8.2% CAGR recorded during 2014-2021, predicts Future Market Insights (FMI).
Earlier, thermodynamic hydrate inhibitors (THIs) were used by the oil and gas industry due to their ability to shift the hydrate-equilibrium curve towards lower temperatures and higher pressures. These inhibitors were able to change the activity of water molecules to accelerate the shift.
However, a new group of chemicals called low dosage hydrate inhibitors was developed later and they differed from THIs. Instead of shifting the hydrate curve, the new group interfered with the process of hydrate formation with the help of numerous mechanisms. In addition to this, as the dosage requirement of these inhibitors was lower than that of THIs, these gained high popularity among customers.
Moreover, low dosage hydrate inhibitors can extend the operating life of gas systems, and because of this advantage, their demand is likely to surge among crude oil product manufacturers worldwide. Apart from that, increasing adoption of these inhibitors to introduce combination products is set to drive sales in the forthcoming years.
How will the Urgent Need for Sustainability Influence Sales of Low Dosage Hydrate Inhibitors?
Increasing demand for energy sources is projected to accelerate the need for gas and crude oil extraction worldwide. Rapid industrialization and the ongoing advancements in the fields of oil and gas generation and extraction are also expected to complement the growth of the market.
According to the Energy Information Administration (EIA), in 2019, the total consumption of refined petroleum products was 100,228 millions of barrels per day (Mb/d) globally. This number is anticipated to surge in the forthcoming years, which is likely to push the demand for hydrate inhibitors.
On top of that, the usage of low dosage hydrate inhibitors in various systems help in lowering the environmental carbon footprint. Thus, governments of many countries are expected to implement stringent norms revolving around the usage of eco-friendly inhibitors, thereby fueling the growth.
Also, manufacturers present in the market are exploring novel applications of these inhibitors. To do so, they are investing in product innovations to meet the unmet sustainability needs.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
Which Factors are Driving the U.K. Low Dosage Hydrate Inhibitors Market?
“High Adoption of Anti-agglomerant Hydrate Inhibitors in Offshore Operations to Boost Growth”
Increasing number of offshore oil and gas operations is likely to propel the growth in the U.K. Europe low dosage hydrate inhibitors market is expected to account for 30.2% of the total market share in 2022, finds FMI.
Moreover, surging adoption of anti-agglomerant hydrate inhibitors in offshore operations is projected to boost the market in the U.K. Increasing need for generator maintenance, especially in the gas and crude oil extraction industries is likely to boost the market.
According to CEIC Data, in December 2020, crude oil production was reported at 930.536 barrels/day in the U.K., while in December 2019, it was 1,007.195 barrels/day. This trend is expected to continue throughout the forecast period, thereby augmenting the growth in the U.K. market.
What is the China Low Dosage Hydrate Inhibitors Market Outlook?
“Key Players are Preferring Hydrate Inhibitors for Drilling Exploration Wells”
Rising production of natural gas in offshore areas is anticipated to fuel the growth in China during the forecast period. East Asia low dosage hydrate inhibitors market is set to account for approximately 18.4% of the total market share in 2022, predicts FMI.
In January 2022, for instance, China National Offshore Oil Corporation (CNOOC) announced its plan to accelerate its oil and gas production in 2022 by 10%, compared to 2021’s goal. The company is aiming to drill 360 exploration wells and initiate 13 projects this year. Such innovative steps taken by key players in the country are expected to support the market.
Furthermore, China became the world’s largest Liquefied Natural Gas (LNG) importer in the first 10 months of 2021. Between January and October, the country’s LNG imports stood at 10.3 Bcf/d, which exhibited a 24% surge, as compared to the same period in 2020. The demand for LNG is anticipated to rise in this country, which, in turn, is likely to bolster the sales of low dosage hydrate inhibitors over the assessment period.
Why is the Canada Low Dosage Hydrate Inhibitors Market Exhibiting High Demand?
“Researchers are Focusing on Finding Green Hydrate Inhibitors to Comply with Norms”
Increasing focus on environmental compliances in the oil & gas sector is set to bolster the demand for biodegradable materials in Canada. As per FMI, North America low dosage hydrate inhibitors market is anticipated to account for 16.0% of share in 2022.
In addition to that, thermodynamic hydrate inhibitors are being substituted with green alternatives as these require high dosage rates. Many educational institutions in Canada are also conducting extensive research and development activities to come up with eco-friendly alternatives.
As per a study published in the National Center for Biotechnology Information (NCBI), researchers at the Queen's University found that antifreeze proteins have the ability to transform the structure II tetrahydrofuran hydrate crystal morphologies.
They are superior hydrate inhibitors than the kinetic inhibitor called poly-N-vinylpyrrolidone. Also, these proteins can be used to create biologically based hydrate inhibitors in future. Backed by these factors, demand is expected to gain momentum in Canada over the forecast period.
Category-wise Insights
Which is the Most Preferred Product Type?
“Ability to Reduce Capital and Transportation Costs is Driving Demand for AA Inhibitors”
By product type, the anti-agglomerate (AA) inhibitors segment is expected to dominate the low dosage hydrate inhibitors market in the forthcoming years. Growth is attributable to their high compatibility, relatively lower transportation costs, and reduced capital costs.
Besides this, they provide superior performance in terms of maximum achievable sub-cooling, as compared to kinetic hydrate inhibitors (KHIs), as AA inhibitors do not have any limit to the maximum allowable shut-in time.
On top of that, AA inhibitors are specially designed to keep hydrates dispersed in condensate or oil and thus the hydrates separate very slowly from the hydrocarbon liquid. Also, in the presence of a liquid hydrocarbon phase acting as the hydrate crystals carrier, these inhibitors deliver optimal performance, which is expected to boost sales.
Which is the Leading Terrain Type?
“Oil and Gas Industry is Utilizing Inhibitors in Offshore Operations to Reduce Capital Expenses”
Based on terrain type, the offshore segment is projected to remain at the forefront in the low dosage hydrate inhibitors market in terms of share. These inhibitors can reduce the capital expenses in the offshore oil and gas industry by lowering the injection-rate and chemical-storage requirements.
Further, these often eliminate the need for regeneration as the chemicals are not easily recoverable. This plays a significant role in offshore operations where desk space and payload are critical. They also help in boosting the production rates whenever the flow line or inhibitor-injection capacity is limited. The beneficial properties of low dosage hydrate inhibitors are anticipated to bolster their demand in the offshore terrain.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competition Landscape
Leading players operating in the low dosage hydrate inhibitors market are focusing partnerships with oil and gas companies to conduct exhaustive research and development activities. They are doing so to come up with state-of-the-art solutions that would be able to serve numerous purposes at once. Some of the other players are engaging in acquisitions, collaborations, joint ventures, and capacity expansions to gain a strong foothold in this market. For instance:
- In November 2019, the Journal of Petroleum Exploration and Production Technology published a study on the assessment of hydrates inhibition using monoethylene glycol and low dosage hydrate inhibitors in deep-water production systems. The results showed that low dosage hydrate inhibitors were more cost-effective in controlling the temperature condition. These also led to a potential saving of $500/day after deployment.
- In November 2019, Clariant, a multinational specialty chemicals company based in Switzerland, developed a High Throughput Experimentation (HTE) platform for augmenting new product development. The platform combines intelligent analytics and automation to automate all aspects of development, such as synthesis, test planning, results analysis, formulation, and application testing. It was used to develop the first product in a line of next-generation AA-low dosage hydrate inhibitors.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2022-2029 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
Units for Volume and US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa. |
|
Key Countries Covered |
United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
|
Key Market Segments Covered |
Product Type, Terrain Type, and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Low Dosage Hydrate Inhibitors Market by Category
Product Type:
- Anti-agglomerate (AA) Inhibitors
- Kinetic Hydrate Inhibitors (KHIs)
Terrain Type:
- Onshore
- Offshore
Region:
- North America
- Latin America
- Europe
- Oceania
- East Asia
- South Asia
- Middle East & Africa (MEA)
Frequently Asked Questions
The global low dosage hydrate inhibitors market is expected to reach a valuation of US$ 75.3 Mn in 2022.
The global low dosage hydrate inhibitors market grew at a healthy 8.2% CAGR between 2013 and 2021.
The increasing need for sustainable solutions and the surging oil extraction activities are the key trends boosting the sales of low dosage hydrate inhibitors.
BASF SE, Schlumberger, Ashland, Arkema Group, ERO CHEM LLC, Halliburton, Baker Hughes Incorporated, Clariant Chemicals, Ecolab, and GasHydrate LLC are some of the leading players present in the global low dosage hydrate inhibitors market.
The low dosage hydrate inhibitors market in North America is anticipated to account for 16.0% of the share in 2022.
The East Asia low dosage hydrate inhibitors market is projected to account for 18.4% of the share in the forecast period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
3.3. Porter’s Analysis
4. Key Success Factors
4.1. Product Adoption Rate
4.2. Technology Adoption Rate
4.3. Strategic Promotional Strategies
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Offshore Rigs By Region
5.1.3. Global Oil & Gas Production Forecast Outlook
5.1.4. Natural Gas Demand Forecast
5.1.5. Natural Gas Production By Region
5.1.6. Global Energy Consumption
5.1.7. Shale Gas Resources By country
5.1.8. Global Chemical Sales
5.1.9. Parent Market Outlook
5.1.10. Patent Analysis
5.2. Value Chain Analysis
5.2.1. List of Distributors
5.3. Forecast Factors - Relevance & Impact
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
6. Global Low Dosage Hydrate Inhibitors Market Demand Analysis 2013-2021 and Forecast, 2022-2028
6.1. Historical Market Volume (Tons) Analysis, 2013-2021
6.2. Current and Future Market Volume (Tons) Projections, 2022-2028
6.3. Y-o-Y Growth Trend Analysis
6.4. Pricing Analysis
6.5. Global Low Dosage Hydrate Inhibitors Market Demand (000’US$ ) Analysis 2013-2021 and Forecast, 2022-2028
7. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (000’US$ ) and Volume Analysis By Product Type, 2013 - 2021
7.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Product Type, 2022 - 2028
7.3.1. Anti-Agglomerate (AA) inhibitors
7.3.2. Kinetic Hydrate Inhibitors (KHI)
7.4. Market Attractiveness Analysis By Product Type
8. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028, by Terrain Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (000’US$ ) and Volume Analysis By Terrain Type, 2013 - 2021
8.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Terrain Type, 2022 - 2028
8.3.1. Onshore
8.3.2. Offshore
8.4. Market Attractiveness Analysis By Terrain Type
9. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028, by Region
9.1. Introduction
9.2. Historical Market Size (000’US$ ) and Volume Analysis By Region, 2013 - 2021
9.3. Current Market Size (000’US$ ) and Volume Analysis and Forecast By Region, 2022 - 2028
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
10.1. Introduction
10.2. Pricing Analysis
10.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
10.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2022 - 2028
10.4.1. By Country
10.4.1.1. U.S.
10.4.1.2. Canada
10.4.2. By Product Type
10.4.3. By Terrain Type
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By Terrain Type
10.6. Market Trends
10.7. Key Market Participants - Intensity Mapping
10.8. Drivers and Restraints - Impact Analysis
11. Latin America Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
11.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2022 - 2028
11.4.1. By Country
11.4.1.1. Brazil
11.4.1.2. Mexico
11.4.1.3. Rest of Latin America
11.4.2. By Product Type
11.4.3. By Terrain Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Terrain Type
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Europe Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
12.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2022 - 2028
12.4.1. By Country
12.4.1.1. Germany
12.4.1.2. Italy
12.4.1.3. France
12.4.1.4. U.K.
12.4.1.5. Spain
12.4.1.6. BENELUX
12.4.1.7. Russia
12.4.1.8. Rest of Europe
12.4.2. By Product Type
12.4.3. By Terrain Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Terrain Type
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. South Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
13.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2022 - 2028
13.4.1. By Country
13.4.1.1. India
13.4.1.2. Thailand
13.4.1.3. Indonesia
13.4.1.4. Malaysia
13.4.1.5. Rest of South Asia
13.4.2. By Product Type
13.4.3. By Terrain Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Terrain Type
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. East Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
14.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2022 - 2028
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.2. By Product Type
14.4.3. By Terrain Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Terrain Type
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Oceania Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
15.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2022 - 2028
15.4.1. By Country
15.4.1.1. Australia
15.4.1.2. New Zealand
15.4.2. By Product Type
15.4.3. By Terrain Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Terrain Type
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
16.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2022 - 2028
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. Turkey
16.4.1.3. Northern Africa
16.4.1.4. South Africa
16.4.1.5. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By Terrain Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Terrain Type
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Emerging Countries Low Dosage Hydrate Inhibitors Market Analysis 2013-2021 and Forecast 2022-2028
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. Canada Low Dosage Hydrate Inhibitors Market Analysis
17.2.1. Introduction
17.2.2. Pricing Analysis
17.2.3. PEST Analysis
17.2.4. Market Value Proportion Analysis by Market Taxonomy
17.2.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.2.5.1. By Product Type
17.2.5.2. By Terrain Type
17.2.6. Canada Low Dosage Hydrate Inhibitors Market - Competition Landscape
17.2.7. Canada - Trade Analysis
17.3. The U.S. Low Dosage Hydrate Inhibitors Market Analysis
17.3.1. Introduction
17.3.2. Pricing Analysis
17.3.3. PEST Analysis
17.3.4. Market Value Proportion Analysis by Market Taxonomy
17.3.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.3.5.1. By Product Type
17.3.5.2. By Terrain Type
17.3.6. The U.S. Low Dosage Hydrate Inhibitors Market - Competition Landscap
17.4. Brazil Low Dosage Hydrate Inhibitors Market Analysis
17.4.1. Introduction
17.4.2. Pricing Analysis
17.4.3. PEST Analysis
17.4.4. Market Value Proportion Analysis by Market Taxonomy
17.4.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.4.5.1. By Product Type
17.4.5.2. By Terrain Type
17.4.6. Brazil Low Dosage Hydrate Inhibitors Market - Competition Landscape
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Low Dosage Hydrate Inhibitors)
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product foot print by Players
18.4.3. Channel Foot Print by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Pricing Analysis by Competition
19.3. Competition Benchmarking
19.4. Competition Deep Dive
19.4.1. BASF SE
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Profitability by Market Segments (Product/Channel/Region)
19.4.1.4. Sales Footprint
19.4.1.5. Strategy Overview
19.4.1.5.1. Marketing Strategy
19.4.1.5.2. Product Strategy
19.4.1.5.3. Channel Strategy
19.4.2. Schlumberger
19.4.3. Arkema Group
19.4.4. Ashland
19.4.5. ERO CHEM LLC
19.4.6. Halliburton
19.4.7. Baker Hughes Incorporated
19.4.8. Clariant Chemicals
19.4.9. Ecolab
19.4.10. GasHydrate LLC
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 02: Global Low Dosage Hydrate Inhibitors Market Value (000'US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 03: Global Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Region, 2013 – 2028
Table 04: North America Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 05: North America Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 06: North America Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 07: Latin America Low Dosage Hydrate Inhibitors Market Value (000'US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 08: Latin America Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 09: Latin America Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 10: Europe Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 11: Europe Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 12: Europe Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 13: South Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 14: South Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 15: South Asia Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 16: East Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 17: East Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 18: East Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 19: Oceania Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 20: Oceania Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 21: Oceania Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 22: Middle East & Africa Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 23: Middle East & Africa Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 24: Middle East & Africa Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 25: U.S. Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 26: U.S. Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 27: Canada Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 28: Canada Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 29: Brazil Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 30: Brazil Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global GDP Growth Y-o-Y (%) Forecast Comparison by Region, 2016–2028
Figure 02: Global Oil & Gas Production Forecast Outlook
Figure 03: Demand Analysis of Natural Gas
Figure 04: Production of Natural Gas by Region (Bn Cubic Meters)
Figure 05: Global Energy Consumption by Fuel Type (2016)
Figure 06: Global Refined Product Demand by Region (2016)
Figure 07: Shale Gas Resources (Mn Cubic Meters)
Figure 08: World Energy Consumption by Energy Source (Quadrillion Btu)
Figure 09: 10 Prominent Countries of Chemical Sales (2016) by Value
Figure 10: Global Chemical Sales Share (2016) by Region
Figure 11: Global Low Dosage Hydrate Inhibitors Market Value (000'US$) , 2021-2028
Figure 12: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity Analysis, 2013–2028
Figure 13: Global Low Dosage Hydrate Inhibitors Market Value Analysis By Product Type (2022)
Figure 14: Global Low Dosage Hydrate Inhibitors Market Valve Analysis By Product Type (2028)
Figure 15: Global Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 16: Global Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 17: Global Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 18: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Anti-Agglomerate Inhibitors Segment, 2021 – 2028
Figure 19: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Kinetic Hydrate Inhibitors Segment, 2021 – 2028
Figure 20: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2022)
Figure 21: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2028)
Figure 22: Global Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 23: Global Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 24: Global Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 25: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Onshore Segment, 2021 – 2028
Figure 26: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Offshore Segment, 2021 – 2028
Figure 27: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2022)
Figure 28: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2028)
Figure 29: Global Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Region, 2022 & 2028
Figure 30: Global Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Region, 2021-2028
Figure 31: Global Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Region, 2021-2028
Figure 32: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by North America Segment, 2021 – 2028
Figure 33: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Latin America Segment, 2021 – 2028
Figure 34: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Europe Segment, 2021 – 2028
Figure 35: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by South Asia Segment, 2021 – 2028
Figure 35: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by East Asia Segment, 2021 – 2028
Figure 36: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Oceania Segment, 2021 – 2028
Figure 37: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Middle East & Africa Segment, 2021 – 2028
Figure 38: North America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2022 & 2028
Figure 39: North America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2021-2028
Figure 40: North America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2021-2028
Figure 41: North America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by US Segment, 2021 – 2028
Figure 42: North America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Canada Segment, 2021 – 2028
Figure 43: North America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 44: North America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 45: North America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 46: North America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 47: North America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 48: North America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 48: Latin America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2022 & 2028
Figure 49: Latin America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2021-2028
Figure 50: Latin America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2021-2028
Figure 51: Latin America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Brazil Segment, 2021 – 2028
Figure 52: Latin America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Mexico Segment, 2021 – 2028
Figure 53: Latin America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of LA Segment, 2021 – 2028
Figure 54: Latin America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 55: Latin America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 56: Latin America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 57: Latin America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 58: Latin America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 59: Latin America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 60: Europe Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2022 & 2028
Figure 61: Europe Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2021-2028
Figure 62: Europe Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2021-2028
Figure 63: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Germany Segment, 2021 – 2028
Figure 64: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Italy Segment, 2021 – 2028
Figure 65: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by France Segment, 2021 – 2028
Figure 66: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by U.K. Segment, 2021 – 2028
Figure 67: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Spain Segment, 2021 – 2028
Figure 68: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by BENELUX Segment, 2021 – 2028
Figure 69: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Russia Segment, 2021 – 2028
Figure 70: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of Europe Segment, 2021 – 2028
Figure 71: Europe Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 72: Europe Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 73: Europe Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 74: Europe Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 75: Europe Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 76: Europe Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 77: South Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2022 & 2028
Figure 78: South Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2021-2028
Figure 79: South Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2021-2028
Figure 80: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by India Segment, 2021 – 2028
Figure 81: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Thailand Segment, 2021 – 2028
Figure 82: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Indonesia Segment, 2021 – 2028
Figure 83: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Malaysia Segment, 2021 – 2028
Figure 84: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of SA Segment, 2021 – 2028
Figure 85: South Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 86: South Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 87: South Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 88: South Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 89: South Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 90: South Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 91: East Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2022 & 2028
Figure 92: East Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2021-2028
Figure 93: East Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2021-2028
Figure 94: East Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by China Segment, 2021 – 2028
Figure 95: East Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Japan Segment, 2021 – 2028
Figure 96: East Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by South Korea Segment, 2021 – 2028
Figure 97: East Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 98: East Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 99: East Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 100: East Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 101: East Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 102: East Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 103: Oceania Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2022 & 2028
Figure 104: Oceania Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2021-2028
Figure 105: Oceania Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2021-2028
Figure 106: Oceania Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Australia Segment, 2021 – 2028
Figure 107: Oceania Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by New Zealand Segment, 2021 – 2028
Figure 108: Oceania Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 109: Oceania Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 110: Oceania Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 111: Oceania Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 112: Oceania Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 113: Oceania Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 114: Middle East & Africa Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2022 & 2028
Figure 115: Middle East & Africa Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2021-2028
Figure 116: Middle East & Africa Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2021-2028
Figure 117: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by GCC Countries Segment, 2021 – 2028
Figure 118: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Turkey Segment, 2021 – 2028
Figure 119: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Northern Africa Segment, 2021 – 2028
Figure 120: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by South Africa Segment, 2021 – 2028
Figure 121: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of MEA Segment, 2021 – 2028
Figure 122: Middle East & Africa Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2022 & 2028
Figure 123: Middle East & Africa Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2021-2028
Figure 124: Middle East & Africa Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2021-2028
Figure 125: Middle East & Africa Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2022 & 2028
Figure 126: Middle East & Africa Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2021-2028
Figure 127: Middle East & Africa Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2021-2028
Figure 128: Emerging Markets Low Dosage Hydrate Inhibitors Market Share by Country, 2022
Figure 129: Global Low Dosage Hydrate Inhibitors Market Share by Region, 2022
Figure 130: Global & Emerging Countries Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections, 2021-2028
Figure 131: Global & Emerging Countries Low Dosage Hydrate Inhibitors Market Share and BPS Analysis – 2022 & 2028
Need specific information?
Request CustomizationExplore Chemicals & Materials Insights
View Reports
